Published in Women's Health Weekly, November 4th, 2004
M. Todorova of the Medical University of Sofia, Bulgaria, and colleagues studied the effects of hormone replacement therapy (HRT) on immunoglobulin (Ig) G and IgM anticardiolipin (aCL) antibodies.
They divided "30 clinically healthy postmenopausal women with no history of previous thrombotic events or autoimmune disease . . . in two groups: control group (n=12, mean age 52.9 ± 4.5 years, and 6.2 ± 3.6 years duration of amenorrhea) and a second group (n=18, mean age 53.6...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly